Leg ulcers (UDJ) is defined as a chronic skin wound, lasting for more than 4 to 6 weeks,
between the knee and foot, and with no tendency to spontaneous healing.
In 2002, the prevalence of leg ulcers is estimated between 0.5% and 1% of the general
population and 3% in subjects over 65 years.
The sex ratio is generally 3 females to 1 male. It is in most cases a complication of
vascular disease, usually venous (70 to 90%), then blood (5-15%), mixed (5-10%) and
In three quarter of cases, the UDJ is a chronic painful wound to the social repercussions
(sleep disorders, eating, work stoppages) and major economic (individual and collective costs
The treatment of a chronic wound uses validated techniques for several years as the skin
graft in tablets, associated with the etiological treatment.
The latest recommendations HAS implemented to date from 2006 and concerns the management of
leg ulcers predominantly venous.
Few articles in the literature address the possibility of an analgesic effect of the
transplant pellets in the treatment of chronic ulcers algic.
In 2008, a Swedish article, evaluated pain before and after skin grafting in carriers of leg
ulcer patients and feet and showed that there was a reduction in pain post transplant.
We propose to evaluate the analgesic effect of the skin graft in pellet on a patient
population having one or more Algic ulcers.